New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2023-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.26355/eurrev_202305_32328PMID 37203845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer in People with HIV.

  2024cited by this paper
• A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

  2023cited by this paper
• Clinical Evidence of Interaction Between Nutraceutical Supplementation and Platinum-based Chemotherapy.

  2022cited by this paper
• Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers

  2022cited by this paper
• The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies

  2022cited by this paper
• Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity

  2022cited by this paper
• Chemotherapy-Induced Hepatotoxicity in HIV Patients

  2021cited by this paper
• The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma

  2021cited by this paper
• Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience

  2021cited by this paper
• Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment

  2020cited by this paper
• Epstein Barr Virus related cancer in people living with HIV: a review of the literature

  2020cited by this paper
• Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics

  2020cited by this paper
• Non-AIDS defining cancers: a comprehensive update on diagnosis and management.

  2020cited by this paper
• Metastatic Colorectal Cancer: Prognostic And Predictive Factors.

  2020cited by this paper
• Advances in Long-Acting Agents for the Treatment of HIV Infection

  2020cited by this paper
• Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies

  2020cited by this paper
• The Climate in the European Union and the Enlarged European Region is a Determinant of the COVID-19 Case Fatality Ratio

  2020cited by this paper
• HODGKIN ’ S LYMPHOMA IN PEOPLE LIVING WITH HIV : EPIDEMIOLOGY AND CLINICAL MANAGEMENT

  2019cited by this paper
• Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.

  2017cited by this paper
• New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy

  2016cited by this paper
• Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection

  2016cited by this paper
• Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy

  2016cited by this paper
• Lung Cancer in HIV-Infected Patients.

  2016cited by this paper
• Non-small Cell Lung Cancer

  2016cited by this paper
• ANAL CANCER IN HIV-POSITIVE PATIENTS : STATE OF THE ART

  2016cited by this paper
• Lung Malignancies in HIV Infection

  2016cited by this paper
• Clinical management of HIV-associated hematologic malignancies

  2016cited by this paper
• Strategies for Monitoring Outcomes in HIV-Exposed Uninfected Children in the United Kingdom

  2016cited by this paper
• Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma

  2016cited by this paper
• SELECTED PHARMACOGENETIC PANEL TEST FOR TOXICITY PREVENTION OF DRUG-DRUG INTERACTIONS BETWEEN HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ( HAART ) AND ANTIBLASTIC CHEMOTHERAPY

  2015cited by this paper
• Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

  2015cited by this paper
• Management of HIV infection in patients with cancer receiving chemotherapy.

  2014cited by this paper
• Lung cancer in HIV positive patients: the GICAT experience.

  2014cited by this paper
• Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

  2014cited by this paper
• Pharmacotherapy in Cancer Patients With HIV/AIDS

  2014cited by this paper
• Colorectal cancer in elderly patients: from best supportive care to cure.

  2013cited by this paper
• Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients

  2013cited by this paper
• Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients

  2013cited by this paper
• Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests

  2013cited by this paper
• Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients.

  2013cited by this paper
• Cancer-related fatigue in the elderly

  2013cited by this paper
• Knowledge and skills needs for health professions about pharmacogenomics testing field.

  2012cited by this paper
• HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

  2012cited by this paper
• Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study

  2012cited by this paper
• Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.

  2012cited by this paper
• HIV infection, aging, and immune function: implications for cancer risk and prevention

  2012cited by this paper
• Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

  2012cited by this paper
• Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

  2012cited by this paper
• Use of antineoplastic agents in cancer patients with HIV/AIDS

  2012cited by this paper
• Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience.

  2012cited by this paper
• Radiotherapy and hepatocellular carcinoma: update and review of the literature.

  2012cited by this paper
• Hepatocellular carcinoma in HIV-infected patients: check early, treat hard.

  2011cited by this paper
• HIV-Associated Hodgkin Lymphoma

  2011cited by this paper
• Anal cancer: Focus on HIV-positive patients in the HAART-era.

  2011cited by this paper
• HIV-infected patients and liver transplantation: who, when and why.

  2011cited by this paper
• HIV-Positive Patients with Liver Metastases from Colorectal Cancer Deserve the Same Therapeutic Approach as the General Population

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Cancer as a cause of death among people with AIDS in the United States.

  2010cited by this paper
• Hodgkin's Disease in Patients with HIV Infection

  2010cited by this paper
• Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection.

  2010cited by this paper
• The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men.

  2010cited by this paper
• Vital signs: Current cigarette smoking among adults aged >=18 years --- United States, 2009

  2010cited by this paper
• Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

  2010cited by this paper
• Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome.

  2009cited by this paper
• AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.

  2009cited by this paper
• Genetic factors influencing cytarabine therapy.

  2009cited by this paper
• Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma.

  2009cited by this paper
• Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.

  2009cited by this paper
• HIV infection and the risk of cancers with and without a known infectious cause

  2009cited by this paper
• Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.

  2009cited by this paper
• Elevation of clonal serum free light chains in patients with HIV‐negative primary effusion lymphoma (PEL) and PEL‐like lymphoma

  2009cited by this paper
• Clinical Presentation and Outcome of Colorectal Cancer in HIV-Positive Patients: A Clinical Case-Control Study

  2009cited by this paper
• Kaposi’s sarcoma after liver transplantation

  2008cited by this paper
• Hepatocellular carcinoma in HIV patients treated by liver transplantation.

  2008cited by this paper
• FOLFOX-4 Regimen with Concomitant Highly Active Antiretroviral Therapy in Metastatic Colorectal Cancer HIV-Infected Patients: A Report of Five Cases and Review of the Literature

  2008cited by this paper
• Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.

  2008cited by this paper
• Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study

  2008cited by this paper
• Unusual Presentation of Metastatic Hepatocellular Carcinoma in an HIV/HCV Coinfected Patient: Case Report and Review of the Literature

  2008cited by this paper
• Human immunodeficiency virus and liver transplantation: our point of view.

  2008cited by this paper
• Assessing Theoretical Risk and Benefit suggested by Genetic Association Studies of CCR5: Experience in a Drug Development Programme for Maraviroc

  2007cited by this paper
• HIV-associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity.

  2007cited by this paper
• Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

  2007cited by this paper
• AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

  2007cited by this paper
• Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma

  2007cited by this paper
• Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

  2007cited by this paper
• Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era.

  2006cited by this paper
• Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention.

  2006cited by this paper
• Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study.

  2006cited by this paper
• Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.

  2006cited by this paper
• Pharmacogenetic Characteristics of Indinavir, Zidovudine, and Lamivudine Therapy in HIV-Infected Adults: A Pilot Study

  2006cited by this paper
• Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

  2006cited by this paper
• HIV infection and lymphoma

  2006cited by this paper
• Elevated incidence of lung cancer among HIV-infected individuals.

  2006cited by this paper
• MALIGNANT PROGRESSION OF ANAL INTRA‐EPITHELIAL NEOPLASIA

  2006cited by this paper
• Trends in cancer risk among people with AIDS in the United States 1980–2002

  2006cited by this paper
• Rationale and uses of a public HIV drug-resistance database.

  2006cited by this paper
• Hodgkin lymphoma: to the HAART of the matter

  2006cited by this paper
• Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

  2005cited by this paper
• VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

  2005cited by this paper
• Tobacco use and readiness to quit smoking in low-income HIV-infected persons.

  2005cited by this paper

• Use of Tobacco and Alternative Nicotine Products Among People with HIV: A Cross-Sectional Multicenter Survey.

  2025cites this paper
• Navigating the Nexus: HIV and Breast Cancer—A Critical Review

  2024cites this paper
• The iron group transition-metal (Fe, Ru, Os) coordination of Se-doped graphitic carbon (Se@g-C3N4) nanostructures for the smart therapeutic delivery of zidovudine (ZVD) as an antiretroviral drug: a theoretical calculation perspective

  2023cites this paper